Sierra Oncology, Inc.

Sierra Oncology, Inc.verified

SRRA

Price:

$54.99

Market Cap:

$0

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs. Its lead drug candidate, momelotinib, is a selective and orally bioavailable Janus kinase 1 (JAK 1), JAK2, and Activin A receptor type 1 (ACVR1) inhibitor. The company also develops SRA515, a selective bromodomain-containing protein 4 inhibitor; and SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1. It has the license agreements with Carna Biosciences, Inc. to develop and commercialize SRA141, a small molecule kinase inhibitor targeting Cdc7; AstraZeneca AB; and CRT Pione...[Read more]

Industry

Biotechnology

IPO Date

2015-07-16

Stock Exchange

NASDAQ

Ticker

SRRA

The PE Ratio as of November 2025 (TTM) for Sierra Oncology, Inc. (SRRA) is -8.34

According to Sierra Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.34. This represents a change of 165.04% compared to the average of -3.15 of the last 4 quarters.

Sierra Oncology, Inc. (SRRA) Historical PE Ratio (quarterly & annually)

How has SRRA PE Ratio performed in the past?

The mean historical PE Ratio of Sierra Oncology, Inc. over the last ten years is -2.06. The current -8.34 PE Ratio has changed 40.32% with respect to the historical average. Over the past ten years (40 quarters), SRRA's PE Ratio was at its highest in in the December 2019 quarter at -0.43. The PE Ratio was at its lowest in in the December 2017 quarter at -4.60.

Quarterly (TTM)
Annual

Average

-2.06

Median

-1.75

Minimum

-4.46

Maximum

-0.40

Sierra Oncology, Inc. (SRRA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sierra Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 377.05%

Maximum Annual PE Ratio = -0.40

Minimum Annual Increase = -76.77%

Minimum Annual PE Ratio = -4.46

Quarterly (TTM)
Annual
YearPE RatioChange
2021-3.0446.20%
2020-2.08360.55%
2019-0.45-74.18%
2018-1.75-60.48%
2017-4.43377.05%
2016-0.93133.67%
2015-0.40-61.63%
2014-1.04-76.77%

Sierra Oncology, Inc. (SRRA) Average PE Ratio

How has SRRA PE Ratio performed in the past?

The current PE Ratio of Sierra Oncology, Inc. (SRRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.86

5-year avg

-2.35

10-year avg

-2.06

Sierra Oncology, Inc. (SRRA) PE Ratio vs. Peers

How is SRRA’s PE Ratio compared to its peers?

Sierra Oncology, Inc.’s PE Ratio is greater than CinCor Pharma, Inc. (-20.44), less than POINT Biopharma Global Inc. (12.03), less than EQRx, Inc. (5.40), greater than CTI BioPharma Corp. (-11.46), less than VectivBio Holding AG (-7.94), less than Gracell Biotechnologies Inc. (-1.62), less than Ethzilla Corp. (-0.65), less than Verve Therapeutics, Inc. (-5.46), less than Albireo Pharma, Inc. (-5.61),

Build a custom stock screener for Sierra Oncology, Inc. (SRRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sierra Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sierra Oncology, Inc. (SRRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sierra Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sierra Oncology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Sierra Oncology, Inc. (SRRA)?

What is the highest PE Ratio for Sierra Oncology, Inc. (SRRA)?

What is the 3-year average PE Ratio for Sierra Oncology, Inc. (SRRA)?

What is the 5-year average PE Ratio for Sierra Oncology, Inc. (SRRA)?

How does the current PE Ratio for Sierra Oncology, Inc. (SRRA) compare to its historical average?